Marshall Wace, LLP Phasebio Pharmaceuticals Inc C Transaction History

Marshall Wace, LLP

  • $77.3 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022
SELL
N/A
-98,444 Reduced 44.45%
123,039 $73,000
Q1 2022

May 16, 2022
SELL
N/A
-140,687 Reduced 38.85%
221,483 $292,000
Q4 2021

Feb 14, 2022
BUY
N/A
143,293 Added 65.47%
362,170 $945,000
Q3 2021

Nov 15, 2021
BUY
N/A
218,877 New
218,877 $681,000

About PHASEBIO PHARMACEUTICALS INC C

PHASQ Quotes by TradingView
  • Ticker PHASQ
More about PHASQ
Track This Portfolio

Track Marshall Wace, LLP Portfolio

Follow Marshall Wace, LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Marshall Wace, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Marshall Wace, LLP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email